Advancedmolecular
microRNA Gene Regulation
Overview
microRNAs are ~22-nt RNAs that silence genes post-transcriptionally: transcribed as pri-miRNAs, cropped by Drosha, exported, diced by Dicer, and loaded into RISC, where the seed sequence (nt 2-8) pairs with target 3' UTRs to block translation or degrade mRNA. Humans have ~2,000 miRNAs regulating most protein-coding genes; lin-4 (1993, Ambros/Schwartz) founded the field (Nobel 2024 to Ambros and Ruvkun).
Learning objectives
- Outline miRNA biogenesis (Drosha, Dicer, RISC)
- Explain seed-sequence targeting
- Describe miRNA roles in development
- Explain miRNA links to cancer
Biogenesis
Pol II transcribes pri-miRNA hairpins; Drosha-DGCR8 crops them to pre-miRNAs; Exportin-5 exports; Dicer trims to ~22-nt duplexes; one strand loads into Argonaute (RISC). The whole pathway is a repurposed antiviral RNAi system turned to endogenous gene regulation.
Two RNase III cuts convert a hairpin transcript into a gene-silencing guide.
Targeting by the seed
Nucleotides 2-8 (the seed) pair with complementary sites, usually in target 3' UTRs; perfect pairing favors mRNA cleavage (rare in animals), partial pairing blocks translation and recruits deadenylases. One miRNA targets hundreds of mRNAs; one mRNA is hit by many miRNAs: a dense regulatory network.
miRNAs fine-tune networks rather than switching single genes: rheostats, not on/off switches.
Development and physiology
lin-4 and let-7 time C. elegans larval transitions (the founding discovery); miR-1 drives muscle differentiation; miR-124 specifies neurons. Knockouts show developmental timing, stem-cell, and metabolic defects. Circulating miRNAs serve as disease biomarkers.
Each miRNA tunes hundreds of targets, so phenotypes are broad and context-dependent.
Cancer and therapy
OncomiRs (miR-21, miR-155) are overexpressed in tumors; tumor-suppressor miRNAs (let-7, miR-34) are lost. AntagomiRs (anti-miR oligonucleotides) and miRNA mimics are in clinical trials; miravirsen (anti-miR-122) showed the path in hepatitis C.
miRNA drugs work in principle; getting them into the right cells remains the hurdle.
Key points
- miRNAs: ~22-nt guides made by Drosha/Dicer, acting through RISC
- Seed sequence (nt 2-8) targets 3' UTRs: translational block or decay
- One miRNA, hundreds of targets: network fine-tuning
- OncomiRs vs tumor-suppressor miRNAs; antagomiR therapies in trials
Common misconceptions
✓ Truth: Animal miRNAs usually repress translation/deadenylate; slicing needs near-perfect complementarity (common in plants).
✓ Truth: Related but distinct: siRNAs are exogenous/perfect-match slicers; miRNAs are endogenous, partial-match tuners.
Practice questions
Q1. miRNA biogenesis requires, in order,
- Dicer then Drosha
- Drosha then Dicer
- RISC then Drosha
- Pol III only
Nuclear Drosha crops pri-miRNA; cytoplasmic Dicer makes the mature duplex.
Q2. Target recognition depends mainly on the
- Whole miRNA
- Seed sequence (nt 2-8)
- 5' cap
- Poly-A tail
Seed pairing with 3' UTR sites determines targeting.
Q3. The founding miRNA discovery was ___ in C. elegans
- miR-21
- lin-4
- let-7
- miR-122
lin-4 (1993) was the first miRNA; let-7 followed and is conserved to humans.
Click a question to reveal the answer and explanation.
Frequently asked questions
What won the 2024 Nobel in Physiology or Medicine?
Ambros and Ruvkun, for discovering microRNAs (lin-4, let-7) and their role in post-transcriptional regulation.
How do miRNAs differ from siRNAs?
miRNAs: endogenous, partial complementarity, translational repression. siRNAs: often exogenous, perfect match, mRNA cleavage.
Why are circulating miRNAs biomarkers?
They are stable in blood (in vesicles/protein complexes) and their profiles shift characteristically in disease.